SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001395064-24-000056
Filing Date
2024-05-29
Accepted
2024-05-29 06:29:52
Documents
14
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 6-K form6k-4_052924.htm 6-K 11724
2 EX-99.1 executive_compensation.htm EX-99.1 32868
3 GRAPHIC executive_compensation001.jpg GRAPHIC 174024
4 GRAPHIC executive_compensation002.jpg GRAPHIC 220214
5 GRAPHIC executive_compensation003.jpg GRAPHIC 167747
6 GRAPHIC executive_compensation004.jpg GRAPHIC 230747
7 GRAPHIC executive_compensation005.jpg GRAPHIC 196064
8 GRAPHIC executive_compensation006.jpg GRAPHIC 124404
9 GRAPHIC executive_compensation007.jpg GRAPHIC 184311
10 GRAPHIC executive_compensation008.jpg GRAPHIC 204897
11 GRAPHIC executive_compensation009.jpg GRAPHIC 160843
12 GRAPHIC executive_compensation010.jpg GRAPHIC 172183
13 GRAPHIC executive_compensation011.jpg GRAPHIC 187711
14 GRAPHIC executive_compensation012.jpg GRAPHIC 99789
  Complete submission text file 0001395064-24-000056.txt   2970695
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filer) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38757 | Film No.: 24993946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)